BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32320987)

  • 1. Predictors of Hypophosphatemia and Outcomes during Continuous Renal Replacement Therapy.
    Hendrix RJ; Hastings MC; Samarin M; Hudson JQ
    Blood Purif; 2020; 49(6):700-707. PubMed ID: 32320987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Phosphate Containing Solutions with Incident Hypophosphatemia in Critically Ill Patients Requiring Continuous Renal Replacement Therapy.
    Thompson Bastin ML; Adams PM; Nerusu S; Morris PE; Mayer KP; Neyra JA
    Blood Purif; 2022; 51(2):122-129. PubMed ID: 33915554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphate supplementation for hypophosphatemia during continuous renal replacement therapy in adults.
    Song YH; Seo EH; Yoo YS; Jo YI
    Ren Fail; 2019 Nov; 41(1):72-79. PubMed ID: 30909778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and associated risk factors in patients with blood culture positive sepsis and acute kidney injury requiring continuous renal replacement therapy-A retrospective study.
    Järvisalo MJ; Hellman T; Uusalo P
    PLoS One; 2021; 16(4):e0249561. PubMed ID: 33819306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reductions in red blood cell 2,3-diphosphoglycerate concentration during continuous renal replacment therapy.
    Sharma S; Brugnara C; Betensky RA; Waikar SS
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):74-9. PubMed ID: 25538269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Institutional Change in Continuous Renal Replacement Therapy: Nutrition Support Team Resolves Resultant Severe Hypophosphatemia.
    Busch RA; Curtis CS; Kight CE; Leverson GE; Ma Y; Maursetter L; Kudsk KA
    Nutr Clin Pract; 2017 Apr; 32(2):245-251. PubMed ID: 29927525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous renal replacement therapy in patients with HIV/AIDS.
    Guo H; Liu J; Pu L; Hao J; Yin N; Liu Y; Xiong H; Li A
    BMC Nephrol; 2020 Mar; 21(1):95. PubMed ID: 32160882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between the timing of initiation of continuous renal replacement therapy and the prognosis of patients with sepsis-associated acute kidney injury].
    Wu X; Ye J; Sun M; Wang Z; Chen Q; Zhu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Nov; 32(11):1352-1355. PubMed ID: 33463496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of electrolyte-rich dialysate during continuous renal replacement therapy on serum phosphate and potassium in ICU patients.
    Cho A; Lee YK; Park HC
    PLoS One; 2020; 15(9):e0238867. PubMed ID: 32915900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated Venovenous Hemofiltration as a Transitional Renal Replacement Therapy in the Intensive Care Unit.
    Allegretti AS; Endres P; Parris T; Zhao S; May M; Sylvia-Reardon M; Bezreh N; Culbert-Costley R; Ananian L; Roberts RJ; Lopez N; Charytan DM; Tolkoff-Rubin N
    Am J Nephrol; 2020; 51(4):318-326. PubMed ID: 32097936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of different hemodiafiltration solutions on ionemia in long-term CRRT.
    Nalesso F; Garzotto F; Cattarin L; Innico G; Gobbi L; Calò LA
    Int J Artif Organs; 2021 Nov; 44(11):807-815. PubMed ID: 34472996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of early initiation of continuous renal replacement therapy based on the KDIGO classification on the prognosis of critically ill patients with acute kidney injury].
    Chen M; Hu B; Li Q; Liu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):246-51. PubMed ID: 29917340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effect and safety of continuous renal replacement therapy in the treatment of neonatal sepsis-related acute kidney injury.
    Cai C; Qiu G; Hong W; Shen Y; Gong X
    BMC Nephrol; 2020 Jul; 21(1):286. PubMed ID: 32682407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Renal Replacement Therapy Liberation and Outcomes of Critically Ill Patients With Acute Kidney Injury.
    Liu C; Peng Z; Dong Y; Li Z; Song X; Liu X; Andrijasevic NM; Gajic O; Albright RC; Kashani KB
    Mayo Clin Proc; 2021 Nov; 96(11):2757-2767. PubMed ID: 34686364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes in acute kidney injury patients who underwent continuous renal replacement therapy: a single-center experience.
    Rhee H; Jang GS; An YJ; Han M; Park I; Kim IY; Seong EY; Lee DW; Lee SB; Kwak IS; Song SH
    Clin Exp Nephrol; 2018 Dec; 22(6):1411-1419. PubMed ID: 29948445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of clinical predictors for renal recovery and overall mortality in acute kidney injury requiring continuous renal replacement therapy.
    Hansrivijit P; Yarlagadda K; Puthenpura MM; Ghahramani N; Thongprayoon C; Vaitla P; Cheungpasitporn W
    J Crit Care; 2020 Dec; 60():13-22. PubMed ID: 32731101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous renal replacement therapy is associated with acute cardiac stunning in critically ill patients.
    Slessarev M; Salerno F; Ball IM; McIntyre CW
    Hemodial Int; 2019 Jul; 23(3):325-332. PubMed ID: 31094070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Serum Neutrophil Gelatinase-Associated Lipocalin on the Discontinuation of Continuous Renal Replacement Therapy in Critically Ill Patients with Acute Kidney Injury.
    Chen X; Chen Z; Wei T; Li P; Zhang L; Fu P
    Blood Purif; 2019; 48(1):10-17. PubMed ID: 30844791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Impact of Early Versus Late Initiation of Renal Replacement Therapy Based on Early Warning Algorithm in Critical Care Patients With Acute Kidney Injury.
    Tekdöş Şeker Y; Çukurova Z; Özel Bilgi D; Hergünsel O
    Ther Apher Dial; 2020 Aug; 24(4):445-452. PubMed ID: 31661596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictions of Serum Phosphate Concentration during Continuous Renal Replacement Therapy Using a Steady-State Mass Balance Model.
    Leypoldt JK; Echeverri J; Harenski K; Singh K
    Blood Purif; 2024; 53(1):40-48. PubMed ID: 37926075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.